1. Home
  2. FNWB vs AVTX Comparison

FNWB vs AVTX Comparison

Compare FNWB & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • AVTX
  • Stock Information
  • Founded
  • FNWB 1923
  • AVTX 2011
  • Country
  • FNWB United States
  • AVTX United States
  • Employees
  • FNWB N/A
  • AVTX N/A
  • Industry
  • FNWB Banks
  • AVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • AVTX Health Care
  • Exchange
  • FNWB Nasdaq
  • AVTX Nasdaq
  • Market Cap
  • FNWB 95.2M
  • AVTX 88.4M
  • IPO Year
  • FNWB 2015
  • AVTX 2015
  • Fundamental
  • Price
  • FNWB $11.33
  • AVTX $7.04
  • Analyst Decision
  • FNWB Hold
  • AVTX Strong Buy
  • Analyst Count
  • FNWB 1
  • AVTX 4
  • Target Price
  • FNWB $12.00
  • AVTX $33.00
  • AVG Volume (30 Days)
  • FNWB 23.2K
  • AVTX 43.8K
  • Earning Date
  • FNWB 01-29-2025
  • AVTX 03-28-2025
  • Dividend Yield
  • FNWB 2.36%
  • AVTX N/A
  • EPS Growth
  • FNWB N/A
  • AVTX N/A
  • EPS
  • FNWB N/A
  • AVTX N/A
  • Revenue
  • FNWB $50,900,000.00
  • AVTX $820,000.00
  • Revenue This Year
  • FNWB N/A
  • AVTX N/A
  • Revenue Next Year
  • FNWB $11.60
  • AVTX N/A
  • P/E Ratio
  • FNWB N/A
  • AVTX N/A
  • Revenue Growth
  • FNWB N/A
  • AVTX N/A
  • 52 Week Low
  • FNWB $8.91
  • AVTX $4.18
  • 52 Week High
  • FNWB $16.00
  • AVTX $34.46
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 61.09
  • AVTX 40.43
  • Support Level
  • FNWB $10.80
  • AVTX $7.01
  • Resistance Level
  • FNWB $12.10
  • AVTX $8.00
  • Average True Range (ATR)
  • FNWB 0.26
  • AVTX 0.53
  • MACD
  • FNWB 0.09
  • AVTX -0.05
  • Stochastic Oscillator
  • FNWB 55.48
  • AVTX 6.15

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: